These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


127 related items for PubMed ID: 19411751

  • 1. [Expression of VHL and HIF-1alpha and its clinical significance in the lung cancer tissue].
    Peng Z, Shan C, Wang H.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Apr; 34(4):331-4. PubMed ID: 19411751
    [Abstract] [Full Text] [Related]

  • 2. Expression of VHL and HIF-1α and Their Clinicopathologic Significance in Benign and Malignant Lesions of the Gallbladder.
    Yang Z, Yang Z, Xiong L, Huang S, Liu J, Yang L, Miao X.
    Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):534-9. PubMed ID: 21415706
    [Abstract] [Full Text] [Related]

  • 3. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
    Osada R, Horiuchi A, Kikuchi N, Yoshida J, Hayashi A, Ota M, Katsuyama Y, Melillo G, Konishi I.
    Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
    [Abstract] [Full Text] [Related]

  • 4. The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis.
    Ren W, Mi D, Yang K, Cao N, Tian J, Li Z, Ma B.
    Swiss Med Wkly; 2013 Sep; 143():w13855. PubMed ID: 24018850
    [Abstract] [Full Text] [Related]

  • 5. Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma.
    Lee S, Garner EI, Welch WR, Berkowitz RS, Mok SC.
    Gynecol Oncol; 2007 Aug; 106(2):311-7. PubMed ID: 17532031
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].
    Gong K, Zhang N, Na X, Wu G, Yang XY, Xin DQ, Na YQ.
    Zhonghua Wai Ke Za Zhi; 2005 Mar 15; 43(6):390-3. PubMed ID: 15854350
    [Abstract] [Full Text] [Related]

  • 8. [Prognostic value of the expression of vascular endothelial growth factor A and hypoxia-inducible factor 1alpha in patients undergoing surgery for non-small cell lung cancer].
    Honguero Martínez AF, Arnau Obrer A, Figueroa Almazán S, Martínez Hernández N, Guijarro Jorge R.
    Med Clin (Barc); 2014 May 20; 142(10):432-7. PubMed ID: 23948151
    [Abstract] [Full Text] [Related]

  • 9. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof].
    Yu ZT, Zhao HF, Shang XB.
    Zhonghua Yi Xue Za Zhi; 2008 Sep 16; 88(35):2465-9. PubMed ID: 19080625
    [Abstract] [Full Text] [Related]

  • 10. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate KH.
    Oncogene; 2000 Nov 16; 19(48):5435-43. PubMed ID: 11114720
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Loss of VHL expression contributes to epithelial-mesenchymal transition in oral squamous cell carcinoma.
    Zhang S, Zhou X, Wang B, Zhang K, Liu S, Yue K, Zhang L, Wang X.
    Oral Oncol; 2014 Sep 16; 50(9):809-17. PubMed ID: 24998140
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Upregulation of hypoxia-inducible factor-1alpha mRNA and its clinical significance in non-small cell lung cancer.
    Yohena T, Yoshino I, Takenaka T, Kameyama T, Ohba T, Kuniyoshi Y, Maehara Y.
    J Thorac Oncol; 2009 Mar 16; 4(3):284-90. PubMed ID: 19190516
    [Abstract] [Full Text] [Related]

  • 15. Inactivation of von Hippel-Lindau increases ovarian cancer cell aggressiveness through the HIF1α/miR-210/VMP1 signaling pathway.
    Liu T, Zhao L, Chen W, Li Z, Hou H, Ding L, Li X.
    Int J Mol Med; 2014 May 16; 33(5):1236-42. PubMed ID: 24549370
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
    Wiesener MS, Münchenhagen PM, Berger I, Morgan NV, Roigas J, Schwiertz A, Jürgensen JS, Gruber G, Maxwell PH, Löning SA, Frei U, Maher ER, Gröne HJ, Eckardt KU.
    Cancer Res; 2001 Jul 01; 61(13):5215-22. PubMed ID: 11431362
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.